EdgarLookup

SCANSOURCE, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SCANSOURCE, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
1.9%
Profit Margin
Net income ÷ revenue
4%
Return on Assets
Net income ÷ assets
0.97x
Debt-to-Equity
Total liabilities ÷ equity
+7.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2018 Jun 30, 2018 $3.85B Aug 28, 2018
FY2018 Jun 30, 2017 $3.57B Aug 28, 2018
FY2018 Jun 30, 2016 $3.54B Aug 28, 2018

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $3.04B Aug 21, 2025
FY2025 Jun 30, 2024 $3.26B Aug 21, 2025
FY2025 Jun 30, 2023 $3.79B Aug 21, 2025
FY2024 Jun 30, 2022 $3.53B Aug 27, 2024
FY2023 Jun 30, 2021 $3.15B Aug 22, 2023
FY2022 Jun 30, 2020 $3.05B Aug 23, 2022
FY2021 Jun 30, 2019 $3.25B Aug 24, 2021
FY2020 Jun 30, 2018 $3.16B Aug 31, 2020
FY2019 Jun 30, 2017 $3.57B Aug 22, 2019

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Jun 30, 2017 $3.57B Aug 29, 2017
FY2017 Jun 30, 2016 $3.54B Aug 29, 2017
FY2017 Jun 30, 2015 $3.22B Aug 29, 2017
FY2016 Jun 30, 2014 $2.91B Aug 29, 2016
FY2015 Jun 30, 2013 $2.88B Aug 27, 2015
FY2014 Jun 30, 2012 $3.02B Aug 28, 2014
FY2013 Jun 30, 2011 $2.67B Aug 26, 2013
FY2012 Jun 30, 2010 $2.11B Aug 24, 2012
FY2011 Jun 30, 2009 $1.85B Aug 29, 2011

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $408.65M Aug 21, 2025
FY2025 Jun 30, 2024 $399.05M Aug 21, 2025
FY2025 Jun 30, 2023 $449.24M Aug 21, 2025
FY2024 Jun 30, 2022 $426.52M Aug 27, 2024
FY2023 Jun 30, 2021 $350.72M Aug 22, 2023
FY2022 Jun 30, 2020 $355.57M Aug 23, 2022
FY2021 Jun 30, 2019 $392.80M Aug 24, 2021
FY2020 Jun 30, 2018 $369.31M Aug 31, 2020
FY2019 Jun 30, 2017 $383.60M Aug 22, 2019
FY2018 Jun 30, 2016 $355.44M Aug 28, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $71.55M Aug 21, 2025
FY2025 Jun 30, 2024 $77.06M Aug 21, 2025
FY2025 Jun 30, 2023 $89.81M Aug 21, 2025
FY2024 Jun 30, 2022 $88.80M Aug 27, 2024
FY2023 Jun 30, 2021 $10.80M Aug 22, 2023
FY2022 Jun 30, 2020 ($192.65M) Aug 23, 2022
FY2021 Jun 30, 2019 $57.60M Aug 24, 2021
FY2020 Jun 30, 2018 $33.15M Aug 31, 2020
FY2019 Jun 30, 2017 $69.25M Aug 22, 2019
FY2018 Jun 30, 2016 $63.62M Aug 28, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $85.20M Aug 21, 2025
FY2025 Jun 30, 2024 $90.32M Aug 21, 2025
FY2025 Jun 30, 2023 $135.89M Aug 21, 2025
FY2024 Jun 30, 2022 $122.17M Aug 27, 2024
FY2023 Jun 30, 2021 $61.48M Aug 22, 2023
FY2022 Jun 30, 2020 ($64.97M) Aug 23, 2022
FY2021 Jun 30, 2019 $94.73M Aug 24, 2021
FY2020 Jun 30, 2018 $69.01M Aug 31, 2020
FY2019 Jun 30, 2017 $88.24M Aug 22, 2019
FY2018 Jun 30, 2016 $96.88M Aug 28, 2018

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $286.93M Aug 21, 2025
FY2025 Jun 30, 2024 $277.43M Aug 21, 2025
FY2025 Jun 30, 2023 $285.70M Aug 21, 2025
FY2024 Jun 30, 2022 $275.44M Aug 27, 2024
FY2023 Jun 30, 2021 $247.44M Aug 22, 2023
FY2022 Jun 30, 2020 $259.54M Aug 23, 2022
FY2021 Jun 30, 2019 $244.29M Aug 24, 2021
FY2020 Jun 30, 2018 $232.29M Aug 31, 2020
FY2019 Jun 30, 2017 $265.18M Aug 22, 2019
FY2018 Jun 30, 2016 $240.12M Aug 28, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2019 Jun 30, 2019 ($27.13M) Aug 22, 2019
FY2019 Jun 30, 2018 $24.81M Aug 22, 2019
FY2019 Jun 30, 2017 $94.88M Aug 22, 2019
FY2018 Jun 30, 2016 $52.21M Aug 28, 2018
FY2017 Jun 30, 2015 $75.52M Aug 29, 2017
FY2016 Jun 30, 2014 $47.72M Aug 29, 2016
FY2015 Jun 30, 2013 $129.44M Aug 27, 2015
FY2014 Jun 30, 2012 $59.96M Aug 28, 2014
FY2013 Jun 30, 2011 $10.69M Aug 26, 2013
FY2012 Jun 30, 2010 ($78.16M) Aug 24, 2012

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $1.79B Aug 21, 2025
FY2025 Jun 30, 2024 $1.78B Aug 21, 2025
FY2024 Jun 30, 2023 $2.07B Aug 27, 2024
FY2023 Jun 30, 2022 $1.94B Aug 22, 2023
FY2022 Jun 30, 2021 $1.67B Aug 23, 2022
FY2021 Jun 30, 2020 $1.69B Aug 24, 2021
FY2020 Jun 30, 2019 $2.07B Aug 31, 2020
FY2019 Jun 30, 2018 $1.95B Aug 22, 2019
FY2018 Jun 30, 2017 $1.72B Aug 28, 2018
FY2017 Jun 30, 2016 $1.49B Aug 29, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $879.20M Aug 21, 2025
FY2025 Jun 30, 2024 $854.78M Aug 21, 2025
FY2024 Jun 30, 2023 $1.16B Aug 27, 2024
FY2023 Jun 30, 2022 $1.13B Aug 22, 2023
FY2022 Jun 30, 2021 $940.49M Aug 23, 2022
FY2021 Jun 30, 2020 $1.01B Aug 24, 2021
FY2020 Jun 30, 2019 $1.15B Aug 31, 2020
FY2019 Jun 30, 2018 $1.08B Aug 22, 2019
FY2018 Jun 30, 2017 $881.16M Aug 28, 2018
FY2017 Jun 30, 2016 $716.69M Aug 29, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $906.41M Aug 21, 2025
FY2025 Jun 30, 2024 $924.26M Aug 21, 2025
FY2025 Jun 30, 2023 $905.30M Aug 21, 2025
FY2025 Jun 30, 2022 $806.53M Aug 21, 2025
FY2024 Jun 30, 2021 $731.19M Aug 27, 2024
FY2023 Jun 30, 2020 $678.25M Aug 22, 2023
FY2022 Jun 30, 2019 $914.13M Aug 23, 2022
FY2021 Jun 30, 2018 $866.38M Aug 24, 2021
FY2020 Jun 30, 2017 $837.15M Aug 31, 2020
FY2019 Jun 30, 2016 $774.50M Aug 22, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $230.82M Aug 21, 2025
FY2025 Jun 30, 2024 $206.30M Aug 21, 2025
FY2025 Jun 30, 2023 $216.71M Aug 21, 2025
FY2024 Jun 30, 2022 $214.44M Aug 27, 2024
FY2023 Jun 30, 2021 $218.88M Aug 22, 2023
FY2022 Jun 30, 2020 $214.29M Aug 23, 2022
FY2021 Jun 30, 2019 $310.72M Aug 24, 2021
FY2020 Jun 30, 2018 $288.72M Aug 31, 2020
FY2019 Jun 30, 2017 $200.88M Aug 22, 2019
FY2018 Jun 30, 2016 $92.72M Aug 28, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $1.02B Aug 21, 2025
FY2025 Jun 30, 2024 $1.01B Aug 21, 2025
FY2024 Jun 30, 2023 $936.68M Aug 27, 2024
FY2023 Jun 30, 2022 $846.87M Aug 22, 2023
FY2022 Jun 30, 2021 $758.07M Aug 23, 2022
FY2021 Jun 30, 2020 $747.28M Aug 24, 2021
FY2020 Jun 30, 2019 $939.93M Aug 31, 2020
FY2019 Jun 30, 2018 $882.33M Aug 22, 2019
FY2018 Jun 30, 2017 $849.18M Aug 28, 2018
FY2017 Jun 30, 2016 $779.93M Aug 29, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 $126.16M Aug 21, 2025
FY2025 Jun 30, 2024 $185.46M Aug 21, 2025
FY2024 Jun 30, 2023 $36.18M Aug 27, 2024
FY2023 Jun 30, 2022 $37.99M Aug 22, 2023
FY2022 Jun 30, 2021 $62.72M Aug 23, 2022
FY2021 Jun 30, 2020 $29.49M Aug 24, 2021
FY2020 Jun 30, 2019 $19.31M Aug 31, 2020
FY2019 Jun 30, 2018 $25.53M Aug 22, 2019
FY2018 Jun 30, 2017 $56.09M Aug 28, 2018
FY2018 Jun 30, 2016 $61.40M Aug 28, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2012 Jun 30, 2012 $5.43M Aug 24, 2012
FY2012 Jun 30, 2011 $30.43M Aug 24, 2012
FY2011 Jun 30, 2010 $30.43M Aug 29, 2011

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 3 Aug 21, 2025
FY2025 Jun 30, 2024 3 Aug 21, 2025
FY2025 Jun 30, 2023 3 Aug 21, 2025
FY2024 Jun 30, 2022 3 Aug 27, 2024
FY2023 Jun 30, 2021 0 Aug 22, 2023
FY2022 Jun 30, 2020 (7) Aug 23, 2022
FY2021 Jun 30, 2019 2 Aug 24, 2021
FY2020 Jun 30, 2018 1 Aug 31, 2020
FY2019 Jun 30, 2017 2 Aug 22, 2019
FY2018 Jun 30, 2016 2 Aug 28, 2018

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 3 Aug 21, 2025
FY2025 Jun 30, 2024 3 Aug 21, 2025
FY2025 Jun 30, 2023 3 Aug 21, 2025
FY2024 Jun 30, 2022 3 Aug 27, 2024
FY2023 Jun 30, 2021 0 Aug 22, 2023
FY2022 Jun 30, 2020 (7) Aug 23, 2022
FY2021 Jun 30, 2019 2 Aug 24, 2021
FY2020 Jun 30, 2018 1 Aug 31, 2020
FY2019 Jun 30, 2017 2 Aug 22, 2019
FY2018 Jun 30, 2016 2 Aug 28, 2018

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jun 30, 2025 22.22M Aug 21, 2025
FY2025 Jun 30, 2024 24.24M Aug 21, 2025
FY2024 Jun 30, 2023 24.84M Aug 27, 2024
FY2023 Jun 30, 2022 25.19M Aug 22, 2023
FY2022 Jun 30, 2021 25.50M Aug 23, 2022
FY2021 Jun 30, 2020 25.36M Aug 24, 2021
FY2020 Jun 30, 2019 25.41M Aug 31, 2020
FY2019 Jun 30, 2018 25.59M Aug 22, 2019
FY2018 Jun 30, 2017 25.43M Aug 28, 2018
FY2017 Jun 30, 2016 25.61M Aug 29, 2017